Cargando…

The Top 100 Highly Cited Original Articles on Immunotherapy for Childhood Leukemia

Background: Childhood leukemia is one of the most common cancers in children. As a potential treatment for leukemia, immunotherapy has become a new research hotspot. This research aimed at exploring the status and trends of current researches on immunotherapy for childhood leukemia through bibliomet...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhong, Qing, Li, Bing-Hui, Zhu, Qi-Qi, Zhang, Zhi-Min, Zou, Zhi-Hao, Jin, Ying-Hui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6769078/
https://www.ncbi.nlm.nih.gov/pubmed/31611792
http://dx.doi.org/10.3389/fphar.2019.01100
_version_ 1783455177841311744
author Zhong, Qing
Li, Bing-Hui
Zhu, Qi-Qi
Zhang, Zhi-Min
Zou, Zhi-Hao
Jin, Ying-Hui
author_facet Zhong, Qing
Li, Bing-Hui
Zhu, Qi-Qi
Zhang, Zhi-Min
Zou, Zhi-Hao
Jin, Ying-Hui
author_sort Zhong, Qing
collection PubMed
description Background: Childhood leukemia is one of the most common cancers in children. As a potential treatment for leukemia, immunotherapy has become a new research hotspot. This research aimed at exploring the status and trends of current researches on immunotherapy for childhood leukemia through bibliometric analysis. Methods: The Institute for Scientific Information Web of Science core collection database was searched for articles on immunotherapy and childhood leukemia using a computer. Time period for retrieval was from the beginning of the database to June 15, 2019. The top 100 highly cited articles were selected to extract their information on publication year, authors, title, publication journal, number of citations, author’s affiliations, country, and so on. These general information and bibliometric data were collected for analysis. VOSviewer software was used to generate a figure for keywords’ co-occurrence network and a figure for researcher’s coauthorship network that visualized reference and cooperation patterns for different terms in the 100 articles. Results: The number of citations in the top 100 articles ranged from 17 to 471. These articles were published in 52 different publications. The top four journals in terms of the number of our selected articles were Leukemia (11 articles), Blood (10 articles), Bone Marrow Transplantation (6 articles), and Clinical Cancer Research. The most frequently nominated author was T. Klingebiel from Goethe University Frankfurt, and of the top 100 articles, 12 listed his name. These top 100 articles were published after the year 2000. Most of these articles were original (67%). The United States and Germany were the major countries researching immunotherapy for childhood leukemia and made significant contributions to the combat against the disease. Adoptive immunotherapy and stem cell transplantation appeared more frequently in keywords. Conclusions: This study analyzed the top 100 highly cited articles on immunotherapy for childhood leukemia and provided insights into the features and research hotspots of the articles on this issue.
format Online
Article
Text
id pubmed-6769078
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-67690782019-10-14 The Top 100 Highly Cited Original Articles on Immunotherapy for Childhood Leukemia Zhong, Qing Li, Bing-Hui Zhu, Qi-Qi Zhang, Zhi-Min Zou, Zhi-Hao Jin, Ying-Hui Front Pharmacol Pharmacology Background: Childhood leukemia is one of the most common cancers in children. As a potential treatment for leukemia, immunotherapy has become a new research hotspot. This research aimed at exploring the status and trends of current researches on immunotherapy for childhood leukemia through bibliometric analysis. Methods: The Institute for Scientific Information Web of Science core collection database was searched for articles on immunotherapy and childhood leukemia using a computer. Time period for retrieval was from the beginning of the database to June 15, 2019. The top 100 highly cited articles were selected to extract their information on publication year, authors, title, publication journal, number of citations, author’s affiliations, country, and so on. These general information and bibliometric data were collected for analysis. VOSviewer software was used to generate a figure for keywords’ co-occurrence network and a figure for researcher’s coauthorship network that visualized reference and cooperation patterns for different terms in the 100 articles. Results: The number of citations in the top 100 articles ranged from 17 to 471. These articles were published in 52 different publications. The top four journals in terms of the number of our selected articles were Leukemia (11 articles), Blood (10 articles), Bone Marrow Transplantation (6 articles), and Clinical Cancer Research. The most frequently nominated author was T. Klingebiel from Goethe University Frankfurt, and of the top 100 articles, 12 listed his name. These top 100 articles were published after the year 2000. Most of these articles were original (67%). The United States and Germany were the major countries researching immunotherapy for childhood leukemia and made significant contributions to the combat against the disease. Adoptive immunotherapy and stem cell transplantation appeared more frequently in keywords. Conclusions: This study analyzed the top 100 highly cited articles on immunotherapy for childhood leukemia and provided insights into the features and research hotspots of the articles on this issue. Frontiers Media S.A. 2019-09-24 /pmc/articles/PMC6769078/ /pubmed/31611792 http://dx.doi.org/10.3389/fphar.2019.01100 Text en Copyright © 2019 Zhong, Li, Zhu, Zhang, Zou and Jin http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Zhong, Qing
Li, Bing-Hui
Zhu, Qi-Qi
Zhang, Zhi-Min
Zou, Zhi-Hao
Jin, Ying-Hui
The Top 100 Highly Cited Original Articles on Immunotherapy for Childhood Leukemia
title The Top 100 Highly Cited Original Articles on Immunotherapy for Childhood Leukemia
title_full The Top 100 Highly Cited Original Articles on Immunotherapy for Childhood Leukemia
title_fullStr The Top 100 Highly Cited Original Articles on Immunotherapy for Childhood Leukemia
title_full_unstemmed The Top 100 Highly Cited Original Articles on Immunotherapy for Childhood Leukemia
title_short The Top 100 Highly Cited Original Articles on Immunotherapy for Childhood Leukemia
title_sort top 100 highly cited original articles on immunotherapy for childhood leukemia
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6769078/
https://www.ncbi.nlm.nih.gov/pubmed/31611792
http://dx.doi.org/10.3389/fphar.2019.01100
work_keys_str_mv AT zhongqing thetop100highlycitedoriginalarticlesonimmunotherapyforchildhoodleukemia
AT libinghui thetop100highlycitedoriginalarticlesonimmunotherapyforchildhoodleukemia
AT zhuqiqi thetop100highlycitedoriginalarticlesonimmunotherapyforchildhoodleukemia
AT zhangzhimin thetop100highlycitedoriginalarticlesonimmunotherapyforchildhoodleukemia
AT zouzhihao thetop100highlycitedoriginalarticlesonimmunotherapyforchildhoodleukemia
AT jinyinghui thetop100highlycitedoriginalarticlesonimmunotherapyforchildhoodleukemia
AT zhongqing top100highlycitedoriginalarticlesonimmunotherapyforchildhoodleukemia
AT libinghui top100highlycitedoriginalarticlesonimmunotherapyforchildhoodleukemia
AT zhuqiqi top100highlycitedoriginalarticlesonimmunotherapyforchildhoodleukemia
AT zhangzhimin top100highlycitedoriginalarticlesonimmunotherapyforchildhoodleukemia
AT zouzhihao top100highlycitedoriginalarticlesonimmunotherapyforchildhoodleukemia
AT jinyinghui top100highlycitedoriginalarticlesonimmunotherapyforchildhoodleukemia